Use of magnetic resonance imaging for anatomical phenotyping of the R6/2 mouse model of Huntington's disease

Neurobiology of Disease

Volumn 33, Issue 1, 2009, Pages 12-19

  Sawiak, S J ^a   Wood, N I ^a   Williams, G B ^a   Morton, A J ^a,b   Carpenter, T A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Magnetic resonance imaging; Manual volumetry; Neurodegeneration; R6 2 mice

Indexed keywords

AMYGDALOID NUCLEUS; ANATOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN CORTEX; BRAIN SIZE; CAPSULA INTERNA; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; FEMALE; GENOTYPE; GLOBUS PALLIDUS; HIPPOCAMPUS; HUNTINGTON CHOREA; LATERAL BRAIN VENTRICLE; MALE; MORPHOLOGY; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING;

AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; BRAIN; CEREBRAL CORTEX; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; FEMALE; HIPPOCAMPUS; HUNTINGTON DISEASE; INTERNAL CAPSULE; LATERAL VENTRICLES; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, TRANSGENIC; ORGAN SIZE; PHENOTYPE; STATISTICS, NONPARAMETRIC;

EID: 57449088803     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.09.017     Document Type: Article

References (40)

1. Ashburner J., and Friston K.J. Voxel-based morphometry - the methods. NeuroImage 11 6 Pt 1 (2000) 805-821
2. Ashburner J., and Friston K.J. Unified segmentation. NeuroImage 26 3 (2005) 839-851
3. Bates G., Harper P.S., and Jones L. Huntington's Disease (2002), Oxford University Press, Oxford
4. Benveniste H., Kim K., Zhang L., and Johnson G.A. Magnetic resonance microscopy of the C57BL mouse brain. NeuroImage 11 6 Pt 1 (2000) 601-611
5. Carter R.J., Lione L.A., Humby T., Mangiarini L., Mahal A., Bates G.P., Dunnett S.B., and Morton A.J. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 19 8 (1999) 3248-3257
6. Carter R.J., Hunt M.J., and Morton A.J. Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington's disease gene. Mov. Disord. 15 5 (2000) 925-937
7. Davies S.W., Turmaine M., Cozens B.A., DiFiglia M., Sharp A.H., Ross C.A., Scherzinger E., Wanker E.E., Mangiarini L., and Bates G.P. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90 3 (1997) 537-548
8. DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P., and Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277 5334 (1997) 1990-1993
9. 10 and remacemide in transgenic mouse models of Huntington's disease. J. Neurosci. 22 5 (2002) 1592-1599
10. Hennig J., Nauerth A., and Friedburg H. RARE imaging: a fast imaging method for clinical MR. Magn. Reson. Med. 3 6 (1986) 823-833
11. Hockly E., Cordery P.M., Woodman B., Mahal A., van Dellen A., Blakemore C., Lewis C.M., Hannan A.J., and Bates G.P. Environmental enrichment slows disease progression in R6/2 Huntington's disease mice. Ann. Neurol. 51 2 (2002) 235-242
12. Jenkins B.G., Andreassen O.A., Dedeoglu A., Leavitt B., Hayden M., Borchelt D., Ross C.A., Ferrante R.J., and Beal M.F. Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease. J. Neurochem. 95 (2005) 553-562
13. Johnson G.A., Cofer G.P., Gewalt S.L., and Hedlund L.W. Morphologic phenotyping with MR microscopy: the visible mouse. Radiology 222 3 (2002) 789-793
14. Junqueira L.C., Carneiro J., and Kelley R.O. Basic Histology (1992), Appleton & Lange
15. Koshibu K., Levitt P., and Ahrens E.T. Sex-specific, postpuberty changes in mouse brain structures revealed by three-dimensional magnetic resonance microscopy. NeuroImage 22 4 (2004) 1636-1645
16. Lee W.-T., and Chang C. Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease. Prog. Neurobiol. 72 (2004) 87-110
17. Lerch J.P., Carroll J.B., Spring S., Bertram L.N., Schwab C., Hayden M.R., and Henkelman R.M. Automated deformation analysis in the YAC128 Huntington disease mouse model. NeuroImage 39 (2008) 32-39
18. Lerch J.P., Carroll J.B., Dorr A., Spring S., Evans A.C., Hayden M.R., Sled J.G., and Henkelman R.M. Cortical Thickness Measured From MRI In The YAC128 Mouse Model Of Huntington's Disease. NeuroImage 41 (2008) 243-251
19. Li J.Y., Popovic N., and Brundin P. The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies. NeuroRx. 2 3 (2005) 447-464
20. Lucas A.J., Hawkes R.C., Ansorge R.E., Williams G.B., Nutt R.E., Clark J.C., Fryer T.D., and Carpenter T.A. Development of a combined microPET-MR system. Technol. Cancer Res. Treat. 5 4 (2006) 337-341
21. Ma Y., Hof P.R., Grant S.C., Blackband S.J., Bennett R., Slatest L., McGuigan M.D., and Benveniste H. A three-dimensional digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopy. Neuroscience 135 4 (2005) 1203-1215
22. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S.W., and Bates G.P. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87 3 (1996) 493-506
23. McDaniel B., Sheng H., Warner D.S., Hedlund L.W., and Benveniste H. Tracking brain volume changes in C57BL/6J and ApoE-deficient mice in a model of neurodegeneration: a 5-week longitudinal micro-MRI study. NeuroImage 14 6 (2001) 1244-1255
24. Paulsen J.S., Magnotta V.A., Mikos A.E., Paulson H.L., Penziner E., Andreasen N.C., and Nopoulos P.C. Brain structure in preclinical Huntington's disease. Biol. Psychiatry 59 (2006) 57-63
25. Paxinos G., and Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates (2004), Elsevier Academic Press, London
26. Pluim J.P., Maintz J.B., and Viergever M.A. Mutual-information-based registration of medical images: a survey. IEEE Trans. Med. Imag. 22 8 (2003) 986-1004
27. Press W.H. Numerical Recipes in C: The Art Of Scientific Computing (1992), Cambridge University Press, Cambridge
28. Roberts T.P.L., Carpenter T.A., and Hall L.D. A simple method for the construction of 180° refocusing RF pulses for use in nuclear magnetic resonance imaging. J. Magn. Reson., Ser. B 101 1 (1993) 78-82
29. Roberts T.J., Price J., Williams S.C.R., and Modo M. Preservation of striatal tissue and behavioural function after neural stem cell transplantation in a rat model of Huntington's disease. Neuroscience 139 (2006) 1187-1199
30. Rosas H.D., Koroshetz W.J., Chen Y.I., Skeuse C., Vangel M., Cudkowicz M.E., Caplan K., Marek K., Seidman L.J., Makris N., Jenkins B.G., and Goldstein J.M. Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 60 10 (2003) 1615-1620
31. Rosas H.D., Tuch D.S., Hevelone N.D., Zaleta A.K., Vangel M., Hersch S.M., and Salat D.H. Diffusion tensor imaging in presymptomatic and early Huntington's disease: selective white matter pathology and its relationship to clinical measures. Mov. Disord. 21 9 (2006) 1317-1325
32. Sathasivam K., Hobbs C., Turmaine M., Mangiarini L., Mahal A., Bertaux F., Wanker E.E., Doherty P., Davies S.W., and Bates G.P. Formation of polyglutamine inclusions in non-CNS tissue. Hum. Mol. Genet. 8 (1999) 813-822
33. Stack E.C., Kubilus J.K., Smith K., Cormier K., Del Signore S.J., Guelin E., Ryu H., Hersch S.M., and Ferrante R.J. Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice. J. Comp. Neurol. 490 4 (2005) 354-370
34. Studholme C., Hill D.L., and Hawkes D.J. An overlap invariant entropy measure of 3D medical image alignment. Pattern Recogn. 32 1 (1999) 71-86
35. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 6 (1993) 971-983
36. Turmaine M., Raza A., Mahal A., Mangiarini L., Bates G.P., and Davies S.W. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc. Natl. Acad. Sci. 97 14 (2000) 8093-8097
37. von Hörsten S., Schmitt I., Nguyen H.P., Holzmann C., Schmidt T., Walther T., Bader M., Pabst R., Kobbe P., Krotova J., Stiller D., Kask A., Vaarmann A., Rathke-Hartlieb S., Schulz J.B., Grasshoff U., Bauer I., Vieira-Saecker A.M.M., Paul M., Jones L., Lindenberg K.S., Landwehrmeyer B., Bauer A., Li X.J., and Riess O. Transgenic rat model of Huntington's disease. Hum. Mol. Genet. 12 6 (2003) 617-624
38. Vonsattel J.P., and DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 57 5 (1998) 369-384
39. Wood N.I., Pallier P.N., Wanderer J., and Morton A.J. Systemic administration of Congo red does not improve motor or cognitive function in R6/2 mice. Neurobiol. Dis. 25 2 (2007) 342-353
40. Wood N.I., Goodman A.O., van der Burg J.M., Gazeau V., Brundin P., Björkqvist M., Petersén A., Tabrizi S.J., Barker R.A., and Morton A.J. Increased thirst and drinking in Huntington's disease and the R6/2 mouse. Brain Res. Bull. 76 1-2 (2008) 70-79